DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Intrinsic Value
DaShenLin Pharmaceutical Group Co., Ltd. engages in the retail and wholesale of pharmaceutical products. [ Read More ]
The intrinsic value of one DaShenLin Pharmaceutical Group Co Ltd stock under the Base Case scenario is 47.42 CNY. Compared to the current market price of 21.78 CNY, DaShenLin Pharmaceutical Group Co Ltd is Undervalued by 54%.
Valuation Backtest
DaShenLin Pharmaceutical Group Co Ltd
Run backtest to discover the historical profit from buying and selling DaShenLin Pharmaceutical Group Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
DaShenLin Pharmaceutical Group Co Ltd
| Current Assets | 9.9B |
| Cash & Short-Term Investments | 3.7B |
| Receivables | 1.4B |
| Other Current Assets | 4.7B |
| Non-Current Assets | 11.5B |
| Long-Term Investments | 150.3m |
| PP&E | 6.3B |
| Intangibles | 3.5B |
| Other Non-Current Assets | 1.6B |
| Current Liabilities | 9.2B |
| Accounts Payable | 3B |
| Accrued Liabilities | 249.1m |
| Short-Term Debt | 3.7B |
| Other Current Liabilities | 2.3B |
| Non-Current Liabilities | 5.4B |
| Long-Term Debt | 4.3B |
| Other Non-Current Liabilities | 1.1B |
Earnings Waterfall
DaShenLin Pharmaceutical Group Co Ltd
|
Revenue
|
24.2B
CNY
|
|
Cost of Revenue
|
-15.4B
CNY
|
|
Gross Profit
|
8.8B
CNY
|
|
Operating Expenses
|
-6.8B
CNY
|
|
Operating Income
|
2B
CNY
|
|
Other Expenses
|
-687.5m
CNY
|
|
Net Income
|
1.3B
CNY
|
Free Cash Flow Analysis
DaShenLin Pharmaceutical Group Co Ltd
Profitability Score
Profitability Due Diligence
DaShenLin Pharmaceutical Group Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
DaShenLin Pharmaceutical Group Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
DaShenLin Pharmaceutical Group Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
DaShenLin Pharmaceutical Group Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
DaShenLin Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 34.93 CNY with a low forecast of 29.19 CNY and a high forecast of 40.25 CNY.
Shareholder Return
Price
DaShenLin Pharmaceutical Group Co Ltd
| Average Annual Return | 28.94% |
| Standard Deviation of Annual Returns | 45.39% |
| Max Drawdown | -73% |
| Market Capitalization | 24.7B CNY |
| Shares Outstanding | 1 136 010 812 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
DaShenLin Pharmaceutical Group Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 38,353 full-time employees. The company went IPO on 2017-07-31. The firm's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The firm mainly conducts its business within domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one DaShenLin Pharmaceutical Group Co Ltd stock under the Base Case scenario is 47.42 CNY.
Compared to the current market price of 21.78 CNY, DaShenLin Pharmaceutical Group Co Ltd is Undervalued by 54%.
You don't have any saved screeners yet
